BEYOND NODULES AND CAVITIES LIFE-THREATENING CENTRAL AIRWAY STENOSIS IN GRANULOMATOSIS WITH POLYANGIITIS

  • Marija Jordanoska Internal Medicine Resident
  • Blagica Pecanova Dungevska General Hospital Strumica, North Macedonia
  • Andrea Veljanovska Stojanovski Polyclinic Manolevi, Skopje, North Macedonia
  • Irfan Ismaili University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Suzana Arbutina University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Rabije Mustafa University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia

Abstract

Introduction Granulomatosis with polyangiitis is a systemic necrotizing vasculitis that predominantly involves the upper respiratory tract, lungs, and kidneys. Airway stenosis represents an uncommon but potentially life-threatening complication. Case report : We report the case of a 46-year-old male with biopsy-proven granulomatosis with polyangiitis and chronic obstructive pulmonary disease who developed progressive pulmonary destruction, bilateral bronchiectasis, and severe central airway stenosis. During his most recent hospitalization, he presented with worsening dyspnea and hypoxemic respiratory insufficiency. Imaging revealed bilateral mass-like consolidations and cavitating nodules, while bronchoscopy demonstrated critical circular stenosis of the left main bronchus. Chronic colonization with Pseudomonas aeruginosa was confirmed. The patient required systemic corticosteroids, antibiotic therapy, and long-term oxygen support. Endobronchial stent placement was recommended as a potential therapeutic option. Conclusion This case highlights the importance of early recognition of airway involvement in advanced granulomatosis with polyangiitis and the need for multidisciplinary management.


Keywords: granulomatosis with polyangitis, airway stenosis, dyspnea, respiratory insufficiency, bronchoscopy, endobronchial stent.

References

1. Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.1001885.
2. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. BMJ. 2007;335(7624):806-808. doi:10.1136/bmj.39335.541782.AD.
3. Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1):241. doi:10.1186/s12874-021-01440-5.
4. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. doi:10.1097/01.mlr.0000182534.19832.83.
5. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.
6. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128-138. doi:10.1097/EDE.0b013e3181c30fb2.
7. Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17:230. doi:10.1186/s12916-019-1466-7.
8. Barros AJD, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21. doi:10.1186/1471-2288-3-21.
9. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706. doi:10.1093/aje/kwh090.
10. Reyes LF, Garcia-Gallo E, Murthy S, Fuentes YV, Serrano CC, Ibáñez-Prada ED, et al. Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: a prospective, multinational, observational study. J Crit Care. 2023;77:154318. doi:10.1016/j.jcrc.2023.154318.
11. Ali AS, Sheikh D, Chandler TR, Furmanek S, Huang J, Ramirez JA, et al. Cardiovascular complications are the primary drivers of mortality in hospitalized patients with SARS-CoV-2 community-acquired pneumonia. Chest. 2023;163(5):1051-1060. doi:10.1016/j.chest.2022.11.013.
12. Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):6317. doi:10.1038/s41467-020-19741-6.
13. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi:10.1136/bmj.m1985.
Published
2026-11-18
How to Cite
JORDANOSKA, Marija et al. BEYOND NODULES AND CAVITIES LIFE-THREATENING CENTRAL AIRWAY STENOSIS IN GRANULOMATOSIS WITH POLYANGIITIS. Journal of Morphological Sciences, [S.l.], v. 9, n. 3, p. 181-188, nov. 2026. ISSN 2545-4706. Available at: <https://www.jms.mk/jms/article/view/vol9no3-23>. Date accessed: 18 nov. 2026.
Section
Case Report